Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Ann Surg Oncol. 2010 Aug 12;17(12):3370–3378. doi: 10.1245/s10434-010-1147-4

FIG. 2.

FIG. 2

Disease-specific survival is shown for true MSI colorectal cancers (positive on 3-marker test), false MSI cancers (positive on NCI 5-marker test but negative on 3-marker test), and MSS cancers. True MSI cancers have favorable prognosis compared with the other groups (P < .01)